Health Care Commentary

The Trump administration is planning to propose one of the biggest changes to Medicare in decades. The draft rule aims to reduce government spending by linking Medicare drug reimbursement rates to the rates in more than a dozen other Western countries that use price controls to hold...

Late last month, Senators Lamar Alexander, R-Tenn., and Patty Murray, D-Wash., released bipartisan health reform legislation. The package isn't perfect. But it does include some positive elements—including measures to improve price transparency, ban anti-competitive practices, and boost vaccination rates. Consider how the draft legislation would tackle the excesses...

President Trump is expected to issue an executive order soon that could require insurers and hospitals to disclose the prices they've negotiated for various services. He hopes such transparency will increase competition and drive down health spending. The health care industry is less supportive. The nation's...

The U.S. economy thrives on innovation. According to the U.S. Patent and Trademark Office, industries that intensively rely on intellectual property (IP) protections, which includes the biopharmaceutical industry, account for nearly 40 percent of the U.S. economy and are responsible for an outsized share of our...

A team of investigative reporters recently released a scathing analysisof the Obama administration's decade-old push to digitize patient health records. The report, conducted by Fortune Magazine and Kaiser Health News, revealed that electronic health records were responsible for thousands of serious, even fatal, medical errors. Needless to say,...

Last week, Gov. Jay Inslee, D-Wash., signed a bill to create a state-chartered insurance plan to be sold on the state's insurance exchange. That makes the Evergreen State the first in the nation to offer a "public option." State officials claim the new plan gives consumers one more option on...

Before leaving office, former Food and Drug Administration Commissioner Scott Gottlieb told the Senate Appropriations Committee that Congress should create a new requirement for opioid approvals. New opioids should have to demonstrate superiority over those already on the market, he said. That would be a departure...